Enjoy complimentary customisation on priority with our Enterprise License!
The pain management devices market size is forecast to increase by USD 3.11 billion, at a CAGR of 9.45% between 2023 and 2028. The market is witnessing significant growth, driven by the increasing prevalence of chronic diseases among the geriatric population.
The market continues to evolve, driven by advancements in technology and the growing prevalence of chronic pain conditions. Neuropathic and nociceptive pain, inflammatory and acute, necessitate a multifaceted approach to effective management. Pain monitoring systems enable real-time assessment, while medication adherence tools ensure patients take prescribed medications as directed. Pain clinics and rehabilitation centers offer comprehensive care, integrating various modalities such as neuromodulation devices, radiofrequency ablation, and epidural steroid injections. These interventions, along with surgical options and laser therapy, offer relief for those suffering from chronic pain. Non-opioid analgesics, topical agents, and adjunctive therapies like ultrasound and occupational therapy, play crucial roles in managing pain.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
Implantable pain pumps and drug delivery systems provide long-term relief, while patient education and physical therapy empower individuals to manage their pain effectively. The ongoing unfolding of market activities reveals a dynamic landscape, with new technologies and applications continually emerging. Pain assessment scales and nerve blocks offer valuable insights into pain severity and potential treatment options, further enhancing the ability to provide effective pain management solutions. The musculoskeletal disorder segment is the second largest segment of the application and was valued at USD 1.27 billion in 2022.
With an aging demographic, the demand for effective pain management solutions is on the rise. Furthermore, technological advances in ablation devices are revolutionizing pain treatment, offering minimally invasive and precise solutions. However, the market faces challenges, including the high cost of neurostimulation devices and procedures, which may limit accessibility for some patients.
Companies in this market must navigate these challenges by exploring cost-effective solutions and collaborating with healthcare providers to offer affordable financing options. By focusing on innovation and accessibility, players can capitalize on the growing demand for pain management devices and meet the needs of an aging population.
The pain management devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The neuropathic pain segment is estimated to witness significant growth during the forecast period. The segment was valued at USD 1.58 billion in 2022. It continued to the largest segment at a CAGR of 6.37%.
The market is witnessing significant growth due to the increasing prevalence of chronic pain conditions, particularly neuropathic pain. Neuropathic pain, characterized by damaged or dysfunctional nerve fibers sending incorrect signals to pain centers, affects a large and growing population, especially those with diabetes or prediabetes management. Topical analgesics, implantable pain pumps, neuromodulation devices, and non-opioid analgesics are among the solutions employed in managing this complex, chronic condition. Technological advancements have led to innovations in pain monitoring systems, medication adherence tools, and multimodal pain management approaches. Other interventions, such as ultrasound therapy, facet joint injections, radiofrequency ablation, epidural steroid injections, surgical interventions, laser therapy, opioid analgesics, nerve blocks, and adjunctive therapies, are also utilized in pain clinics and rehabilitation centers.
Patient education, physical therapy, and occupational therapy play crucial roles in managing pain effectively. Inflammatory pain and acute pain management also require specialized attention. Home healthcare and drug delivery systems, including peripheral nerve stimulation and trigger point injections, further expand the market landscape.
The Neuropathic pain segment was valued at USD 1.24 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 48% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
In the market, North America holds the largest share due to the rising prevalence of chronic conditions like diabetes, cancer, and arthritis. Data suggests that the future opportunities for growth in the North America region estimates to be around USD 3.11 billion. The region's large geriatric population, increasing healthcare expenditure, and technological advancements driving innovative devices are significant growth factors. Patients' growing awareness of pain management options, approvals of new products, and the presence of both global and local manufacturers contribute to market expansion. Chronic pain conditions, such as neuropathic and inflammatory pain, are treated through various methods, including topical analgesics, implantable pain pumps, neuromodulation devices, non-opioid analgesics, ultrasound therapy, facet joint injections, pain monitoring systems, medication adherence, and multimodal pain management.
Acute pain management methods, such as nerve blocks, surgical interventions, epidural steroid injections, radiofrequency ablation, laser therapy, opioid analgesics, occupational therapy, rehabilitation centers, home healthcare, peripheral nerve stimulation, drug delivery systems, trigger point injections, patient education, physical therapy, and nociceptive pain treatments, are also employed. Adjunctive therapies, including pain assessment scales, medication adherence tools, and patient education programs, enhance the effectiveness of pain management strategies. The market's growth is further fueled by the increasing demand for minimally invasive procedures, the integration of digital health technologies, and the rising focus on personalized pain management solutions.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global pain management devices market size and forecast projects growth, driven by pain management devices market trends 2024-2028. B2B pain device solutions leverage advanced pain relief technologies for efficacy. Pain management devices market growth opportunities 2025 include devices for chronic pain and portable pain relief devices, meeting patient needs. Pain device management software optimizes operations, while pain management devices market competitive analysis highlights key manufacturers. Sustainable pain device practices align with eco-friendly medical trends. Pain management devices regulations 2024-2028 shapes pain device demand in North America 2025. Non-invasive pain solutions and premium pain device insights boost adoption. Pain devices for home use and customized pain relief devices target niches. Pain management devices market challenges and solutions address cost, with direct procurement strategies for pain devices and pain device pricing optimization enhancing profitability. Data-driven pain device analytics and smart pain relief trends drive innovation.
The pain management devices market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the pain management devices market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, pain management devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - The company specializes in advanced pain management solutions, including the Proclaim SCS system, which utilizes spinal cord stimulation technology to effectively manage chronic pain for patients. This non-invasive device delivers targeted electrical pulses to the spinal cord, providing relief and improving overall quality of life. The technology is backed by extensive clinical research and has been proven effective in managing various types of pain.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Pain Management Devices Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
172 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.45% |
|
Market growth 2024-2028 |
USD 3113.9 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
8.42 |
|
Key countries |
US, China, India, Germany, Japan, UK, South Korea, Canada, Brazil, France, UAE, and Italy |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this pain management devices market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Market Segmentation by Product Type
9 Market Segmentation by End-User
10 Market Segmentation by Technology
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
